Compare Chewy Inc (CHWY) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chewy Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Chewy Inc trades at $22.57 (market cap $9.20B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 8.9× Chewy Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Chewy Inc pays none. Which is the better fit depends on your goals.
| CHWY | REGN | |
|---|---|---|
Market Cap | $9.20B | $82.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $42.33 | $812.27 |
52-Week Low | $17.51 | $555.51 |
Enterprise Value | $9.16B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Chewy Inc
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
